FOSTER CITY, CA and AUSTIN, TX – Applied Biosystems Group (NYSE: ABI), an Applera Corporation business, announced that it has completed the previously announced acquisition of the Research Products Division of Ambion, Inc., a premium provider of innovative products for the study and analysis of ribonucleic acid (RNA), the central molecule used in gene expression and regulation.
The research and development, manufacturing, and other operations of Ambion’s Research Products Division will continue to be based in Austin, Texas and its approximately 300 employees will be integrated into the Applied Biosystems’ global workforce of approximately 4,000 employees. Ambion will become a center of excellence within the Molecular Biology Division’s consumables business with a focus on expanding the range of innovative consumables products in the Applied Biosystems portfolio.
Founded in 1989, Ambion develops and supplies products for stabilizing, synthesizing, isolating, detecting, amplifying and quantifying RNA (ribonucleic acid).
Recent Ambion product introductions include cutting-edge reagents associated with microRNA (miRNA) and RNA interference (RNAi).